Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties
暂无分享，去创建一个
P. Linsley | J. Bajorath | R. Peach | J. Greene | C. Larsen | T. Pearson | S. Cowan | A. Adams | D. Hagerty | J. Emswiler | Daniel C. Anderson | J. Naemura | R. Townsend | K. Price | N. Shirasugi | P. Tso | Lori A Turk | Elizabeth StrobertM | JoAnne L. Greene